EX-FILING FEES

Please wait

EXHIBIT 107

Calculation of Filing Fee Table

Form S-8

(Form Type)

EyePoint Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

Security
Type

Security

Class

Title

Fee

Calculation

Rule

Amount
Registered⁽¹⁾

Proposed

Maximum

Offering

Price Per

Unit

Maximum

Aggregate

Offering

Price

Fee

Rate

Amount of
Registration

Fee

Equity

Common Stock, par value

$0.001 per share, reserved

for issuance pursuant to

the EyePoint

Pharmaceuticals, Inc.

2019 Employee Stock

Purchase Plan

Other

250,000 ⁽²⁾

$8.205 ⁽⁴⁾

$2,051,250.00 ⁽⁴⁾

0.0001476

$302.77

Equity

Common Stock, par value $0.001 per share, reserved for issuance pursuant to the EyePoint Pharmaceuticals, Inc. 2023 Long-Term Incentive Plan

Other

4,000,000 ⁽³⁾

$8.205 ⁽⁴⁾

$32,820,000 ⁽⁴⁾

0.0001476

$4,844.23

Equity

Common Stock, par value $0.001 per share, issuable under the Nonqualified Stock Option Award (Inducement Grant)

Rule 457(h)

15,000 ⁽⁵⁾

$6.69 ⁽⁶⁾

$100,350.00 ⁽⁶⁾

0.0001476

$14.81

Equity

Common Stock, par value $0.001 per share, issuable under the Nonqualified Stock Option Award (Inducement Grant)

Rule 457(h)

13,000 ⁽⁵⁾

$19.55 ⁽⁶⁾

$254,150.00 ⁽⁶⁾

0.0001476

$37.51

Equity

Common Stock, par value $0.001 per share, issuable under the Nonqualified Stock Option Award (Inducement Grant)

Rule 457(h)

10,000 ⁽⁵⁾

$22.76 ⁽⁶⁾

$227,600.00 ⁽⁶⁾

0.0001476

$33.59

Equity

Common Stock, par value $0.001 per share, issuable under the Nonqualified Stock Option Award (Inducement Grant)

Rule 457(h)

49,000 ⁽⁵⁾

$29.08 ⁽⁶⁾

$1,424,920.00 ⁽⁶⁾

0.0001476

$210.32

Equity

Common Stock, par value $0.001 per share, issuable under the Nonqualified Stock Option Award (Inducement Grant)

Rule 457(h)

125,000 ⁽⁵⁾

$28.00 ⁽⁶⁾

$3,500,000.00 ⁽⁶⁾

0.0001476

$516.60

Equity

Common Stock, par value $0.001 per share, issuable under the Nonqualified Stock Option Award (Inducement Grant)

Rule 457(h)

77,000 ⁽⁵⁾

$21.48 ⁽⁶⁾

$1,653,960.00 ⁽⁶⁾

0.0001476

$244.12

Equity

Common Stock, par value

$0.001 per share, issuable

under the Nonqualified

Stock Option Award

(Inducement Grant)

Rule 457(h)

50,500 ⁽⁵⁾

$21.28 ⁽⁶⁾

$1,074,640.00 ⁽⁶⁾

0.0001476

$158.62

Equity

Common Stock, par value $0.001 per share, issuable under the Nonqualified Stock Option Award (Inducement Grant)

Rule 457(h)

44,200 ⁽⁵⁾

$12.94 ⁽⁶⁾

$571,948.00 ⁽⁶⁾

0.0001476

$84.42

Equity

Common Stock, par value $0.001 per share, issuable under the Nonqualified Stock Option Award (Inducement Grant)

Rule 457(h)

25,000 ⁽⁵⁾

$9.38 ⁽⁶⁾

$234,500.00 ⁽⁶⁾

0.0001476

$34.61

Equity

Common Stock, par value $0.001 per share, issuable under the Nonqualified Stock Option Award (Inducement Grant)

Rule 457(h)

57,700 ⁽⁵⁾

$10.54 ⁽⁶⁾

$608,158.00 ⁽⁶⁾

0.0001476

$89.76

Total Offering Amounts

$44,521,476.00

$6,571.36

Total Fees Previously Paid

—

Total Fee Offsets

—

Net Fee Due

$6,571.36

(1)

In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.

(2)	Consists of 250,000 shares of common stock, par value $0.001 per share (“Common Stock”), of EyePoint Pharmaceuticals, Inc. (the “Registrant”) available for issuance under the Registrant’s 2019 Employee Stock Purchase Plan.

(3)	Consists of 4,000,000 shares of Common Stock of Registrant available for issuance under the Registrant’s 2023 Long-Term Incentive Plan.

(4)

Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) and Rule 457(h) of the Securities Act, on the basis of the average of the high and low prices for a share of Common Stock as reported on the Nasdaq Global Market on August 5, 2024, which date is a date within five business days of the filing of this registration statement.

(5)

Represents shares of Common Stock issuable upon the exercise of the nonqualified stock option awards granted to employees of the Registrant between October 16, 2023 and July 15, 2024 as an inducement material to each such employee’s acceptance of employment with the Registrant (the “Inducement Awards”).

(6)	Estimated in accordance with Rule 457(h) of the Securities Act solely for the purpose of calculating the registration fee on the basis of the price at which the Inducement Awards may be exercised.